13 results
424B5
HUGE
FSD Pharma Inc - Ordinary Shares
16 Feb 24
Prospectus supplement for primary offering
6:36pm
attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002 and reduced disclosure obligations regarding executive compensation (to the extent
6-K
EX-99.1
HUGE
FSD Pharma Inc - Ordinary Shares
24 May 22
FSD Pharma Inc. 6-K
9:24am
flexibility to its executive compensation program, the Company adopted an equity incentive plan on May 16, 2022 (the “EIP”) pursuant to which it may grant
6-K
EX-99.1
HUGE
FSD Pharma Inc - Ordinary Shares
23 May 22
Annual General Meeting of the Shareholders
4:29pm
or affiliate of any such persons, in any matter to be acted upon at the Meeting.
- 27 -
STATEMENT OF EXECUTIVE COMPENSATION
Compensation Discussion … and the reasons for their compensation. For a complete understanding of the executive compensation program, this disclosure should be read in conjunction
20-F
2e9sv8mc23glbwbu1l3
31 Mar 22
Annual report (foreign)
8:09am
6-K
EX-99.1
z0b85 c2q0b
5 May 21
Current report (foreign)
11:30am
6-K
EX-99.1
p3u ag8ftpqb2mtbpt
23 Apr 21
Current report (foreign)
5:24pm
40FR12B
EX-99.17
zvhmai8k96u
6 Dec 19
Initial registration of securities (Canada)
12:28pm
40FR12B
EX-99.7
s8y96
6 Dec 19
Initial registration of securities (Canada)
12:28pm
40FR12B
EX-99.28
ruj2ev
6 Dec 19
Initial registration of securities (Canada)
12:28pm
40FR12B
EX-99.36
gd9i4 z90
6 Dec 19
Initial registration of securities (Canada)
12:28pm
40FR12B
EX-99.45
eyp 9sqa584gz
6 Dec 19
Initial registration of securities (Canada)
12:28pm
- Prev
- 1
- Next